hs-CRP Interpretation in Athletes: Why the Cardiovascular-Risk Reference Range Misreads Training-Driven Elevations, the Ferritin and Iron-Status Cross-Talk the Intake Must Integrate, and the Post-Session Draw-Timing Correction That Separates the Real Cases

A 32-year-old marathon runner arrives at intake with a lipid-and-inflammation cardiovascular-risk panel drawn at a routine primary-care physical two weeks earlier. Her hs-CRP reads 4.8 mg/L — flagged in bold on the report against the AHA/CDC "high cardiovascular risk" threshold of 3.0 mg/L — and her primary-care physician's cover note recommends beginning a low-dose statin for "elevated cardiovascular inflammation" alongside a workup for occult infection. Her total cholesterol is 178 mg/dL, LDL 102 mg/dL, HDL 68 mg/dL, triglycerides 74 mg/dL, and fasting glucose 84 mg/dL. Her hemoglobin is 13.6 g/dL, her ferritin reads 76 ng/mL (unremarkable on the sedentary reference), her transferrin saturation is 22%, and her white blood cell count is 5.8 x 10^9/L with a normal differential. She has no fever, no unexplained weight loss, no rash, no joint symptoms, no dysuria, no cough, no sinus symptoms, and no first-degree family history of premature coronary artery disease. Her training week over the past nine months has held at 65 to 80 miles across 6 to 7 sessions with a 20 to 22-mile long run each Saturday and a peak block preceding a marathon PR attempt three months out; her nutrition history is unremarkable and holds at approximately 2,800 kcal/day, 1.4 g/kg protein, and a Mediterranean-pattern base; her supplement stack is a daily multivitamin, 1 g fish oil, and 2,000 IU vitamin D3; she takes no prescription medications; she reports no NSAID use; her sleep averages 7.5 hours per night; and her body mass index is 20.4 with a waist-to-height ratio of 0.42. The draw was taken 36 hours after her Saturday long run.

She is in your office because she wants a second opinion before she starts a statin on a lipid panel that does not otherwise fit the cardiovascular-risk pattern, and because her online research has surfaced the training-load-driven acute-phase response as a possible explanation for the hs-CRP flag that her primary-care physician did not address.

The standard hs-CRP interpretation — the AHA/CDC cardiovascular-risk-stratification framework that categorizes values below 1.0 mg/L as low risk, 1.0 to 3.0 mg/L as average risk, and above 3.0 mg/L as high risk — was validated against general-population cohorts (Physicians' Health Study, Women's Health Study, JUPITER) where the dominant driver of chronic hs-CRP elevation is metabolic-syndrome-associated inflammation running through visceral adiposity, insulin resistance, atherosclerotic disease progression, and periodontal disease. In the trained endurance athlete drawing within 24 to 72 hours of a hard training session or race, that framework misclassifies. Endurance exercise elicits an acute-phase inflammatory response with hs-CRP peaking 24 to 48 hours after prolonged or high-intensity exercise and returning toward baseline over the subsequent 48 to 96 hours. The magnitude of the acute elevation scales with session duration, eccentric load, and heat exposure; a marathon or half-marathon race can push hs-CRP into the 10 to 50 mg/L range for 24 to 72 hours post-event in an otherwise healthy runner. Draws taken inside this window without the draw-timing capture routinely misclassify training-derived acute-phase elevations as chronic cardiovascular-risk-flag findings.

Layer on the specific nutrition-history variables the intake must integrate: the omega-3 intake as a chronic hs-CRP modulator, the vitamin D status as a chronic hs-CRP modulator, the dietary pattern (Mediterranean-pattern intakes correlate with lower baseline hs-CRP; ultra-processed-food-heavy patterns correlate with higher), the alcohol pattern (heavy intake raises), the sleep-debt overlay (short sleep raises baseline hs-CRP within a training block), the body-composition overlay (visceral adiposity is the single largest chronic driver), the periodontal-health status (often overlooked but a meaningful driver), the supplement stack for NSAID use and other anti-inflammatory exposures, and the acute-illness history for the two-to-four weeks preceding the draw (URI, GI infection, dental infection, minor injury, vaccination).

Most sports-RD intakes do not run a structured hs-CRP workup. The panel arrives from primary care, the hs-CRP flag drives a reflexive statin conversation or an occult-infection workup, the draw-timing artifact is not corrected, the [iron status workup](/blog/iron-status-workup-in-female-athletes) is not integrated even where hs-CRP is meaningfully modifying the ferritin read, and the case gets managed as a cardiovascular-risk problem when the actual clinical picture sits in the intersection of training-load-driven acute-phase response, chronic dietary and lifestyle modulators, ferritin cross-talk, and (in a subset of cases) a genuine chronic-inflammation or occult-infection driver the panel is finally surfacing.

This post is the hs-CRP workup I run when the standard cardiovascular-risk panel returns an hs-CRP flag in an endurance or high-training-load athlete and the primary-care assumption of cardiovascular-inflammation origin does not fit the picture. The six-dimension interpretive frame, the acute-vs-chronic draw-timing correction that separates the training-derived spike from the chronic baseline, the ferritin and iron-status cross-talk that the intake must integrate (hs-CRP is an acute-phase modifier of the iron read and can push a functionally iron-deficient athlete into an artifactually normal ferritin range), the metabolic-syndrome and body-composition overlay, the four-quadrant clinical matrix, the medical-coordination triggers, the common counseling mistakes, and the SOAP pattern that documents the case defensibly against the statin-referral or infection-workup read.

Why the standard hs-CRP interpretation under-flags the athletic case

Three structural reasons.

The AHA/CDC reference cutoffs were derived from sedentary-cohort cardiovascular-risk validation. The 1.0 mg/L and 3.0 mg/L thresholds were validated against general-population outcomes cohorts where the median physical-activity load sits far below the endurance-athlete pattern and where the dominant driver of chronic hs-CRP elevation is metabolic-syndrome-associated. The training-derived acute-phase response was not modeled into the cutoffs because the validation populations did not run 65-mile weeks with a 22-mile long run on Saturday. Trained endurance athletes present with a distribution of post-training hs-CRP values that routinely crosses the 3.0 mg/L threshold in the 24-to-72-hour window off a long or hard session without any evidence of cardiovascular pathology.

hs-CRP is an acute-phase reactant with a well-characterized post-exercise timecourse. Prolonged endurance exercise (marathon, ultramarathon, long-course triathlon), high-intensity intervals with meaningful eccentric load, and hot-environment exercise elicit an interleukin-6-mediated hepatic acute-phase response with hs-CRP peaking 24 to 48 hours after the session and normalizing over 48 to 96 hours. The magnitude scales with duration, intensity, eccentric component, heat exposure, and the athlete's training status (less-trained athletes and unaccustomed exposures generate larger responses). Marathon efforts can push post-race hs-CRP into the 10 to 50 mg/L range for 24 to 72 hours in otherwise healthy runners. The primary-care panel drawn 36 hours after the athlete's Saturday long run sits squarely inside this window and captures the training spike rather than the chronic baseline.

hs-CRP cross-talk with the iron read confounds parallel interpretation. Hepcidin is upregulated by IL-6-driven acute-phase inflammation; the iron-panel ferritin is itself an acute-phase reactant and rises with systemic inflammation. An athlete drawn inside the acute-phase window with a training-driven hs-CRP elevation of 4.8 mg/L can present with a ferritin that looks reassuring on the sedentary reference range when the underlying iron status is functionally low. The primary-care read that flags hs-CRP but does not integrate the ferritin correction misses the case where the athlete has both a training-derived hs-CRP spike and a masked iron insufficiency the acute-phase read is hiding. The workup that fails to run the paired-panel correction over-treats the hs-CRP finding and under-treats the iron finding.

The six-dimension hs-CRP workup

Dimension 1: Read against the draw timing and the acute-phase overlay. The single most valuable interpretive variable is the interval between the last hard training session or race and the blood draw. Post-session hs-CRP elevations peak at 24 to 48 hours and normalize over the subsequent 48 to 96 hours in the trained athlete; the workup that captures the draw-timing and the specifics of the preceding 72 hours (session type, duration, intensity, eccentric load, heat exposure) can separate the acute training-derived response from the chronic baseline. The 32-year-old marathon runner drawn 36 hours after a 22-mile long run is inside the peak-response window; the workup does not stop there, but the interpretation weight-adjusts for the timing and schedules a redraw 5 to 7 days off any hard session to establish the chronic baseline.

Dimension 2: Redraw off training to establish the chronic baseline. The single most valuable clinical action in the athletic hs-CRP workup where the initial draw sits inside the acute-response window is the redraw at least 5 to 7 days off any hard training session (a light easy day is fine, a threshold or long or race effort is not). The redraw at the chronic baseline is the value that drives the cardiovascular-risk read; the acute-response value drives the training-load read. Where the redraw drops the value below the 3.0 mg/L cutoff, the case is a training-derived acute-phase presentation and the cardiovascular-risk framework does not apply on the initial number. Where the redraw remains elevated, the workup moves into the chronic-driver differential.

Dimension 3: Ferritin and iron-status cross-talk correction. Ferritin is an acute-phase reactant and rises with systemic inflammation; hepcidin is upregulated by IL-6-driven inflammation and functionally lowers dietary iron absorption and reticuloendothelial iron release. The paired ferritin-hs-CRP read is the corrected interpretation: an athlete with elevated hs-CRP inside the acute-response window and a ferritin that reads in the low-normal range on the sedentary reference (30 to 100 ng/mL) can be functionally iron-deficient with the ferritin artifactually inflated by the acute-phase response. The workup that suspects the pattern runs the redraw with both hs-CRP and ferritin, reads the corrected ferritin at the chronic-baseline hs-CRP, and integrates with the full [iron status workup](/blog/iron-status-workup-in-female-athletes) where the picture warrants. The male-athlete iron read follows the same acute-phase-correction logic.

Dimension 4: Metabolic-syndrome and body-composition overlay. Visceral adipose tissue is the single largest chronic driver of hs-CRP elevation in the general population, mediated through adipose-tissue IL-6 and TNF-alpha secretion. The lean-appearing endurance athlete is not automatically eliminated from this differential, and the workup that captures waist-to-height ratio, visceral adipose tissue on DEXA where available, triglyceride-to-HDL ratio, fasting insulin or HOMA-IR, and the family and personal history of metabolic syndrome integrates the metabolic-driver contribution against the training-derived and other overlays. The 32-year-old marathon runner with a waist-to-height ratio of 0.42 and a triglyceride-to-HDL ratio of 1.1 sits well below the metabolic-syndrome pattern; a different athlete with the same hs-CRP and a waist-to-height ratio of 0.55 would sit in a different differential.

Dimension 5: Occult-infection, autoimmune, and acute-illness differential. hs-CRP is a non-specific inflammation marker and can be elevated by a broad differential outside the training-and-metabolic pattern: recent viral or bacterial upper-respiratory infection (elevation can persist 2 to 4 weeks post-symptom-resolution), acute gastrointestinal infection, urinary-tract infection, dental or periodontal infection (chronic periodontal disease is a well-characterized chronic hs-CRP driver), skin or soft-tissue infection, recent vaccination (elevation for 1 to 2 weeks post-vaccination), unrecognized musculoskeletal injury with local inflammatory response, autoimmune disease (rheumatoid arthritis, systemic lupus, inflammatory bowel disease, psoriasis, ankylosing spondylitis), and less commonly occult malignancy or organ-specific chronic inflammation. The intake conversation must catch the two-to-four-week acute-illness history, the dental and periodontal history, the joint and rash symptom review, the GI symptom history, the family autoimmune history, and the vaccination timing.

Dimension 6: Dietary and lifestyle modulator overlay. Chronic dietary pattern is a meaningful modulator of baseline hs-CRP. Mediterranean-pattern intakes with high fish, vegetable, and olive-oil content correlate with lower baseline values; ultra-processed-food-heavy intakes correlate with higher. Omega-3 supplementation (EPA and DHA at 1 to 3 g/day) has consistent evidence of a modest hs-CRP-lowering effect. Vitamin D deficiency correlates with elevated baseline hs-CRP and repletion lowers it. Alcohol at heavy intakes raises baseline hs-CRP; light-to-moderate intake has less consistent signals. Sleep debt within a training block acutely raises hs-CRP; consistent 7 to 9 hours of sleep lowers it. Smoking raises meaningfully. Chronic NSAID use suppresses the acute-phase response and can mask the read. The 32-year-old marathon runner on a Mediterranean-pattern base, 1 g fish oil, 2,000 IU vitamin D, no smoking, no heavy alcohol, and 7.5 hours of sleep sits at a low-modulator profile; the residual chronic-baseline value should be low.

The four-quadrant clinical decision matrix

Quadrant 1: hs-CRP modestly elevated (3.0 to 10.0 mg/L), draw taken within 72 hours of a hard training session or race, no fever or symptoms of acute illness, no metabolic-syndrome flags, no autoimmune history, no dental or periodontal red flags, ferritin unremarkable or acute-phase-consistent, lipid panel and other cardiovascular-risk markers unremarkable. The pattern is consistent with a training-derived acute-phase response. Redraw at least 5 to 7 days off any hard session; document the corrected chronic baseline; where the chronic baseline sits below the 3.0 mg/L cutoff the case does not warrant the cardiovascular-risk-flag framework. This is the marathon runner's most likely case pending the redraw.

Quadrant 2: hs-CRP persistently elevated on redraw off training (above 3.0 mg/L sustained), no acute-infection or symptom-based flags, metabolic-syndrome overlay present (waist-to-height above 0.5, elevated triglyceride-to-HDL, elevated fasting insulin, or clinical body-composition or lipid drivers), no autoimmune or periodontal flags. The pattern is consistent with a metabolic-syndrome-associated chronic-inflammation contribution. Intervention pathway includes the standard metabolic-syndrome drivers (dietary pattern shift toward Mediterranean-pattern base, omega-3 optimization to 2 to 3 g/day EPA+DHA if not already there, vitamin D repletion where deficient, body-composition intervention where warranted, alcohol reduction where pattern warrants, sleep-consistency intervention where sleep debt is present, dental hygiene reinforcement). Coordinate with primary care on the extended cardiovascular-risk workup where the lipid panel or family history warrants.

Quadrant 3: hs-CRP markedly elevated (above 10.0 mg/L sustained), or acute clinical symptoms (fever, unexplained weight loss, joint pain, rash, dyspnea, chronic cough, dysuria, GI symptoms), or autoimmune history, or recent unresolved infection, or clinical suspicion of occult infection or malignancy. Medical coordination on the extended workup. The sports-RD role is to surface the training pattern, the acute-illness history, the dental history, and the systemic-symptom review to the medical team, defer intervention pending the workup, and support the medical management with parallel dietetic assessment.

Quadrant 4: Ambiguous panel, mixed signals, or the training-vs-chronic-vs-metabolic differential cannot be resolved on the initial workup. Order the extended follow-on — repeat hs-CRP off training with paired ferritin and iron panel, comprehensive metabolic panel including fasting insulin, extended lipid panel with lipoprotein(a) where family history warrants, 25-hydroxyvitamin D, dental and periodontal review, systemic-symptom review, autoimmune serologies where the picture warrants, and a two-to-four-week follow-up. Coordinate with primary care on the extended workup and defer the statin conversation pending the corrected read.

The acute-phase correction — the practical draw-timing framework

The workup needs the direct capture of the training-load pattern in the 72 hours preceding the initial draw and the scheduled redraw off training.

Session type and intensity in the 72 hours before the draw. Long runs above 90 minutes, tempo or threshold sessions, intervals above lactate threshold, races of any distance, hot-environment exercise, heavy strength training with eccentric emphasis, and unaccustomed training sessions all generate meaningful acute-phase responses. Easy aerobic sessions below approximately 65 minutes and below aerobic threshold intensity generate small responses and typically do not push hs-CRP above the 3.0 mg/L threshold in a trained athlete. The intake conversation must capture the specific sessions in the 72-hour window before the draw.

Environmental and heat exposure. Hot-environment exercise (above approximately 28°C or with high humidity) elicits a larger acute-phase response than the same session in temperate conditions. The heat-acclimation state matters — well-acclimatized athletes generate smaller responses. Race conditions particularly matter for post-race draws.

Training-status and unaccustomed-exposure overlay. Less-trained athletes and unaccustomed exposures generate larger responses than trained-and-adapted athletes and habitual exposures. The athlete new to marathon training or returning from an off-season block presents with larger training-derived hs-CRP elevations than the veteran on a stable block.

Redraw timing. The recommendation is a minimum of 5 to 7 days off any hard training session (a light easy day is fine, a threshold or long or race effort is not) for the chronic-baseline redraw. Where the athlete is inside a training block that cannot accommodate a 5-to-7-day light window, the alternative is to schedule the draw at least 72 hours off the last hard session with the understanding that residual acute-phase effect may still be present. Multiple serial redraws across the training block can establish the athlete-specific baseline where the picture warrants.

Draw timing relative to travel, illness, dental work, and vaccination. The two-to-four-week window preceding the draw needs to be reviewed for acute-illness, recent dental work or extraction, sinus infections, upper-respiratory or GI infections, and recent vaccinations. Any of these can carry residual hs-CRP elevation beyond the acute symptomatic period and should be captured on the intake.

The ferritin and iron-status cross-talk — the practical paired-panel framework

hs-CRP and ferritin move together during acute-phase inflammation. The workup that runs the paired panel and corrects the ferritin read against the hs-CRP context surfaces the functional iron status the isolated ferritin read misses.

Acute-phase-driven ferritin inflation. Ferritin can rise 2 to 3-fold or more during systemic inflammation with the underlying iron stores unchanged. The athlete with hs-CRP at 4.8 mg/L and ferritin at 76 ng/mL on a draw taken inside the acute-response window can have a true baseline ferritin of 30 to 40 ng/mL — functionally iron-limited in an endurance athlete on the athletic-population reference — with the acute-phase response inflating the apparent value into the sedentary-reference reassurance range.

Corrected ferritin interpretation. Where hs-CRP is elevated, the ferritin read should be interpreted against the chronic-baseline hs-CRP rather than the acute-phase value. The redraw at 5 to 7 days off training with paired hs-CRP and ferritin provides the corrected reads.

Transferrin saturation and soluble transferrin receptor as parallel reads. Transferrin saturation is less affected by acute-phase inflammation than ferritin. Soluble transferrin receptor is largely unaffected by acute-phase inflammation and rises with functional iron deficiency; the ratio of soluble transferrin receptor to ferritin (or the log-transformed sTfR/ferritin index) is a robust functional-iron-status read in the setting of inflammation where available. Not all labs run sTfR routinely; coordinate with primary care on the extended panel where the paired hs-CRP-and-ferritin picture is ambiguous.

Integration with the full iron workup. Where the corrected ferritin sits in a functionally low range for the athletic population (see the [iron status workup](/blog/iron-status-workup-in-female-athletes) for the female-athlete threshold discussion; the male-athlete threshold conversation is similar in structure), the intervention pathway is the iron workup rather than the cardiovascular-risk pathway. The workup that catches this integration prevents both the over-treatment of the training-derived hs-CRP finding and the under-treatment of the masked iron finding.

When to refer to medical

Five signals warrant medical referral beyond the dietetic workup.

hs-CRP above 10.0 mg/L on a draw not attributable to a recent identified training or acute-illness exposure, or sustained above 10.0 mg/L across serial draws. The pattern warrants medical evaluation for occult infection, autoimmune disease, or other systemic-inflammation drivers.

Any acute clinical presentation with systemic symptoms — fever, unexplained weight loss, night sweats, unexplained joint pain, rash, dyspnea, chronic cough, dysuria, chronic GI symptoms, blood in stool or urine — with elevated hs-CRP. Medical evaluation regardless of the training or dietary pattern.

Autoimmune family history or personal history warranting the extended autoimmune workup, particularly where joint, skin, or GI symptoms are present alongside the hs-CRP flag. Coordinate with rheumatology or the primary-care team on the ANA, rheumatoid-factor, anti-CCP, ESR, and specific-autoimmune-panel workup.

Concurrent cardiovascular-risk-flag pattern (elevated LDL, low HDL, elevated triglycerides, elevated lipoprotein(a), family history of premature coronary artery disease) with sustained hs-CRP elevation on chronic-baseline redraw. Coordinate with primary care on the cardiovascular-risk-stratification workup and the potential statin conversation on the integrated risk picture, not on the isolated hs-CRP.

Persistent hs-CRP elevation on serial redraws after the identified dietary, lifestyle, and training-timing drivers have been addressed for 8 to 12 weeks. The dietetic and lifestyle-modification non-responder warrants the extended medical workup.

Common counseling mistakes

Reading hs-CRP in isolation and endorsing the statin conversation without the draw-timing correction and the redraw off training. The primary-care read that flags the value and drives the statin trial without running the athletic-physiology corrections misclassifies the training-derived case and generates a lifetime-medication conversation on an artifact.

Missing the ferritin and iron-status cross-talk. The isolated ferritin read in the setting of an elevated hs-CRP is uninterpretable. The workup that fails to run the paired panel and the corrected interpretation over-treats the hs-CRP finding and under-treats a masked iron insufficiency.

Failing to capture the training-load pattern in the 72 hours before the draw. The single most valuable data point in the athletic hs-CRP workup is the interval between the last hard session and the draw. The workup that does not capture it cannot separate acute from chronic.

Missing the two-to-four-week acute-illness and dental history. URI, GI infection, dental infection or recent extraction, and vaccination all carry residual hs-CRP elevation beyond the acute symptomatic period and are routinely missed on the primary-care read.

Endorsing high-dose fish oil, curcumin, or "anti-inflammatory" supplement stacks as the primary intervention without addressing the training-timing, iron cross-talk, or metabolic-driver contribution. Omega-3 optimization at 2 to 3 g/day EPA+DHA has consistent modest-magnitude evidence in the chronic-hs-CRP-elevation case and is a reasonable component of the Quadrant 2 intervention; it is not the correction for the Quadrant 1 training-derived case. Curcumin and other supplement approaches have weaker evidence and are secondary at best.

Missing the metabolic-syndrome differential in the lean-appearing endurance athlete. Metabolic-syndrome-associated inflammation is not eliminated by a normal BMI or a low body-fat percentage. Run the parallel workup where the waist-to-height, triglyceride-to-HDL, or fasting insulin warrants.

Failing to coordinate the cardiovascular-risk conversation on the integrated picture. The isolated hs-CRP does not stand alone as a cardiovascular-risk driver in the athletic population; the integrated picture (family history, lipid panel including lipoprotein(a) where warranted, body composition, blood pressure, glycemic control) is the framework the cardiovascular-risk conversation should run on. Coordinate with primary care rather than either over-endorse or under-endorse the statin conversation.

Where this lands in the SOAP

Subjective section format:

hs-CRP Workup (panel reviewed YYYY-MM-DD):

• hs-CRP: [X mg/L, category vs AHA/CDC cutoffs]
• Draw timing relative to last hard session: [X hours]
• Training-load pattern past 72 hours: [narrative — session type, duration, intensity, eccentric load, heat exposure]
• Redraw plan (off-training, ≥5-7 days off any hard session): [scheduled date]

Paired iron and inflammation panel:

• Ferritin: [X ng/mL — flag as acute-phase-inflated where hs-CRP elevated on same draw]
• Transferrin saturation: [X%]
• Soluble transferrin receptor: [if ordered]
• CBC with differential: [narrative]
• Corrected ferritin interpretation on redraw at chronic-baseline hs-CRP: [narrative]

Acute-illness and dental history (past 2-4 weeks):

• Fever, URI, GI infection, sinus infection, UTI: [narrative]
• Dental work, extraction, periodontal symptoms: [narrative]
• Vaccination timing: [narrative]
• Musculoskeletal injury with local inflammation: [narrative]

Systemic-symptom review:

• Fever, unexplained weight loss, night sweats: [narrative]
• Joint pain, swelling, morning stiffness: [narrative]
• Rash, photosensitivity, mucosal ulcers: [narrative]
• Dyspnea, chronic cough, dysuria, chronic GI symptoms: [narrative]
• Family autoimmune history: [narrative]

Cardiovascular-risk overlay:

• Lipid panel: total, LDL, HDL, triglycerides: [values]
• Lipoprotein(a) where family history warrants: [value or NOT ORDERED — flag]
• Fasting glucose, HbA1c, insulin, HOMA-IR: [values]
• Blood pressure: [value]
• Family history of premature CAD: [narrative]
• Personal history: smoking, prior events, comorbidities: [narrative]

Dietary and lifestyle modulators:

• Dietary pattern (Mediterranean-pattern, ultra-processed-food fraction): [narrative]
• Omega-3 intake (fish frequency, EPA+DHA supplementation dose): [narrative]
• 25-hydroxyvitamin D status: [value or NOT ORDERED — flag]
• Alcohol pattern (AUDIT-C-referenced): [narrative]
• Sleep hours and consistency across training block: [narrative]
• Smoking status: [narrative]
• Chronic NSAID or aspirin use (can suppress acute-phase read): [narrative]

Body-composition and metabolic overlay:

• BMI / waist-to-height ratio / DEXA visceral adipose tissue: [values]
• Triglyceride-to-HDL ratio: [calculated]

Quadrant: [1-4 from clinical matrix]

Clinical impression: [statement integrating draw-timing overlay, paired iron cross-talk, acute-illness and dental history, systemic-symptom review, cardiovascular-risk overlay, dietary and lifestyle modulators, and body-composition and metabolic overlay]

Action: [redraw scheduling / paired iron correction / dietary and lifestyle intervention / medical coordination / observation]

Follow-up: [recheck date, plan, escalation triggers]

Assessment integrates the six-dimension read and assigns the case to a quadrant. Plan documents the differential, the dietary and lifestyle intervention, the medical-coordination communications, and the recheck cadence. See [SOAP notes for sports dietitians](/blog/soap-notes-for-sports-dietitians) for the broader documentation framework.

The dietetic intervention in the responder case

The Quadrant 1 training-derived case does not warrant a dietetic intervention beyond the redraw-off-training protocol. Educate the athlete on the acute-phase response timecourse, the resolution timeline, and the future-panel timing recommendation to schedule elective bloodwork at least 5 to 7 days off any hard session where possible.

The Quadrant 2 metabolic-and-modulator case responds to five intervention levers in most presentations.

Dietary pattern shift toward a Mediterranean-pattern base. High vegetable and fruit intake, high fish frequency (2 to 3 servings per week at minimum), olive oil as the primary added fat, whole-grain rather than refined-grain base, moderate legume and nut intake, moderate dairy, low added sugar and ultra-processed-food fraction. The dietary-pattern intervention is the largest single dietetic lever on chronic hs-CRP.

Omega-3 optimization. EPA+DHA at 2 to 3 g/day through combined dietary (fatty fish frequency) and supplemental sources where dietary alone does not reach the target. The evidence for hs-CRP lowering is consistent though modest in magnitude; the effect stacks with the dietary-pattern intervention.

Vitamin D repletion. Where 25-hydroxyvitamin D is below approximately 30 ng/mL, repletion to 30 to 50 ng/mL through supplementation (typically 2,000 to 5,000 IU/day depending on baseline and sun exposure, with recheck at 8 to 12 weeks) has evidence for modest hs-CRP lowering in the deficient population.

Body-composition intervention where the metabolic overlay warrants. Where the waist-to-height ratio, DEXA visceral adipose tissue, or triglyceride-to-HDL indicates a metabolic-syndrome-associated contribution, the body-composition and metabolic-driver intervention (see the [insulin resistance workup](/blog/insulin-resistance-workup-in-athletes) for the framework) sits alongside the hs-CRP work.

Sleep-consistency and alcohol-reduction intervention where the pattern warrants. Consistent 7 to 9 hours of sleep across the training block and low-to-moderate alcohol intake both lower baseline hs-CRP. The interventions are modest per-lever but stack with the dietary and other levers.

Repeat hs-CRP at 8 to 12 weeks with the paired ferritin and iron panel to confirm the trajectory. Movement toward normalization confirms the identified drivers; failure to move warrants the extended workup and the medical coordination.

Where platform tooling helps

The bottleneck in the hs-CRP workup at scale is the multi-system integration — the hs-CRP value read against the draw timing and the 72-hour training-load pattern, the paired ferritin and iron-status correction against the acute-phase context, the two-to-four-week acute-illness and dental history capture, the systemic-symptom review, the cardiovascular-risk overlay integration, the dietary and lifestyle modulator audit, the metabolic-syndrome and body-composition overlay, and the redraw scheduling and serial-trajectory tracking. The intake that runs the integration by hand drops it on busy weeks; the marathon runner's case gets managed as a statin-trial conversation when the actual differential runs through a Saturday long run 36 hours before the draw and a ferritin read that requires the acute-phase correction.

The leverage is an hs-CRP workup module that ingests the value, prompts for the draw-timing and 72-hour training-load capture, prompts for paired ferritin and iron-panel ordering with acute-phase-corrected interpretation, prompts for the two-to-four-week acute-illness and dental history, runs the systemic-symptom review, integrates with the cardiovascular-risk overlay and the [insulin resistance workup](/blog/insulin-resistance-workup-in-athletes), audits the dietary and lifestyle modulators against the food log and supplement inventory, surfaces the four-quadrant decision matrix, pre-populates the SOAP documentation, tracks the redraw cadence with the ≥5-to-7-day off-training scheduling logic, and manages the medical-coordination communications where escalation is warranted. The RD's job is the clinical judgment and the conversation with the athlete, not the spreadsheet.

The chart trail is defensible — every interpretation tied to the integration context that justified it, every referral documented with the pattern that drove it, every dietary and lifestyle intervention paired with the differential reasoning behind it.

The bottom line

An elevated hs-CRP on a primary-care cardiovascular-risk panel in an endurance or high-training-load athlete is not automatically a cardiovascular-inflammation flag warranting a statin conversation. The AHA/CDC reference cutoffs were calibrated in sedentary cohorts where the dominant driver of chronic hs-CRP elevation is metabolic-syndrome-associated inflammation; endurance exercise elicits an IL-6-mediated acute-phase response with hs-CRP peaking 24 to 48 hours post-session and normalizing over 48 to 96 hours, and draws inside this window without the draw-timing correction routinely misclassify training-derived elevations as chronic cardiovascular-risk findings. hs-CRP is also an acute-phase modifier of the ferritin read; the isolated ferritin in the setting of an elevated hs-CRP is uninterpretable and requires the paired-panel correction on redraw.

The workup that catches the real cases reads hs-CRP against the draw timing and the 72-hour training-load pattern, schedules the chronic-baseline redraw at least 5 to 7 days off any hard session, runs the paired ferritin and iron-panel correction, captures the two-to-four-week acute-illness and dental history, runs the systemic-symptom review, integrates the metabolic-syndrome and body-composition overlay, audits the dietary and lifestyle modulators, and assigns the case to a four-quadrant matrix that drives the intervention pathway. The Quadrant 1 training-derived case gets the redraw-off-training confirmation and no cardiovascular-risk-flag framework. The Quadrant 2 metabolic-and-modulator case gets the dietary pattern shift, the omega-3 and vitamin D optimization, the body-composition and metabolic-driver intervention where warranted, and the sleep-and-alcohol overlay. The Quadrant 3 systemic-symptom or markedly-elevated case gets the medical referral. The Quadrant 4 ambiguous case gets the extended follow-on.

The 32-year-old marathon runner with the 4.8 mg/L hs-CRP drawn 36 hours after a 22-mile long run, on a Mediterranean-pattern diet with omega-3 and vitamin D on board, with a lean body composition and an unremarkable lipid panel and no systemic symptoms, is not the statin-trial case the primary-care panel produced. She is a Quadrant 1 case pending the redraw off training and the paired ferritin correction, and where the workup that runs the integration catches what the reflexive cardiovascular-risk read misses.

[Calsanova's Dietitian plan](/signup?role=dietitian) ships an hs-CRP workup module with draw-timing and 72-hour training-load capture, paired ferritin and iron-panel acute-phase correction, two-to-four-week acute-illness and dental history prompts, systemic-symptom review, metabolic-syndrome and body-composition overlay integration, dietary and lifestyle modulator auditing against the food log and supplement inventory, four-quadrant decision-matrix surfacing, and pre-populated SOAP documentation with medical-coordination communications built in. The clinical judgment stays with the RD; the integration stays off the spreadsheet.